Clinical Trial: Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880795) titled 'Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring' on Oct. 12.

Brief Summary: This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in adults with end-stage kidney disease (ESKD) receiving hemodialysis who have no known history of diabetes.

Participants will wear a Libre 3 Plus CGM sensor for up to 15 days and undergo standard diabetes assessments, including fasting plasma glucose and hemoglobin.

The primary objectives are to:

* Determine the prevalence of previously undiagnosed diabetes among dialysis patients us...